NCT06153693Phase 3Completed

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Study sponsor: Mineralys Therapeutics Inc. · MLYS

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2024-12-10Actual

Enrollment · participants1083Actual

Source updated2026-05-01Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.